Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A field-deployable immunofluorescence chip for adenovirus monitoring in groundwater systems.

Biosensors & bioelectronics·2026
Same author

IgLON5 autoimmune antibodies activate Tau via neuronal hyperactivity.

Science advances·2026
Same author

Immune-metabolic trajectories delineate subgroups in paediatric long COVID.

Nature communications·2026
Same author

Reply to comment: "Before GBS can be attributed to an infection with C. jejuni, this pathogen must be confirmed".

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Comparison of manual with artificial intelligence-aided interpretation of ANA HEp-2 IIF assay patterns in a clinical diagnostics lab.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Roles of zinc in the gut-liver axis.

Annals of hepatology·2026
Same journal

Decoding gut microbiome alterations in celiac disease: Implications for pathogenesis and treatment.

Autoimmunity reviews·2026
Same journal

Rethinking immunosuppression in limited cutaneous systemic sclerosis. The lcSSc conundrum; pros and cons for a timely immunosuppressive treatment.

Autoimmunity reviews·2026
Same journal

Kidney failure in patients with ANCA-associated vasculitis: A systematic review of outcomes.

Autoimmunity reviews·2026
Same journal

The role of antimicrobial peptides in rheumatoid arthritis: From mucosal predisposition to chronic synovitis.

Autoimmunity reviews·2026
Same journal

The role of short-chain fatty acids as key mediators of gut microbiota - host crosstalk in thyroid diseases.

Autoimmunity reviews·2026
Same journal

Intermittent hydrarthrosis (periodic synoviosis): A narrative review.

Autoimmunity reviews·2026
See all related articles

Related Experiment Video

Updated: Jun 1, 2026

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Autoantibody diagnostics in clinical practice.

Karsten Conrad1, Dirk Roggenbuck, Dirk Reinhold

  • 1Institute of Immunology, Technical University Dresden, Germany. karsten.conrad@tu-dresden.de

Autoimmunity Reviews
|May 31, 2011
PubMed
Summary
This summary is machine-generated.

Disease-associated autoantibodies (AAB) aid in early and atypical systemic autoimmune disease diagnosis, prognosis, and monitoring. Advancements require novel AAB discovery, standardized evaluations, and improved diagnostic algorithms for better patient outcomes.

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Experiment Videos

Last Updated: Jun 1, 2026

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Area of Science:

  • Clinical immunology
  • Autoantibody diagnostics
  • Biomarker discovery

Background:

  • Disease-associated autoantibodies (AAB) are crucial for diagnosing systemic autoimmune diseases.
  • AAB aid in early, oligosymptomatic, and atypical disease presentations.
  • AAB are vital for prognosis and monitoring disease activity and therapeutic response.

Purpose of the Study:

  • To highlight key aspects for advancing autoantibody diagnostics in clinical practice.
  • To emphasize the need for novel autoantibody discovery and target identification.
  • To discuss standardization, interpretation challenges, and algorithm development in autoantibody testing.

Main Methods:

  • Review of current practices and future directions in autoantibody diagnostics.
  • Identification of novel clinically relevant autoantibodies and their autoantigenic targets.
  • Analysis of standardization requirements for evaluation studies and detection methods.

Main Results:

  • The search for novel autoantibodies broadens diagnostic capabilities for idiopathic diseases.
  • Standardization of evaluation studies is essential for reliable diagnostic variables.
  • Interpretation of autoantibody tests is increasingly complex due to novel developments.

Conclusions:

  • Autoantibody diagnostics require continuous advancement through novel discoveries and standardized methods.
  • Improved diagnostic algorithms, including multiparametric analyses, are crucial.
  • Addressing interpretation challenges and implementing quality management are vital for enhancing autoantibody diagnostics.